Garneau, Stewart C MD (UIA Investigator) — Moline, Illinois

Garneau, Stewart C MD (UIA Investigator) is a clinical research site located in Moline, Illinois, United States 61265.

Crixeo Clinical Trials Trust Score: 28/100 (FAILING). This profile has not yet been claimed by the site owner.

Garneau, Stewart C MD (UIA Investigator) has participated in 63 clinical trials with 15 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Moline

Browse all research sites in Illinois · View every site in Moline

Sponsor Feasibility Report

Trust Score: 28/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Garneau, Stewart C MD (UIA Investigator)?

Garneau, Stewart C MD (UIA Investigator) has a Crixeo Trust Score of 28/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Garneau, Stewart C MD (UIA Investigator) conducted?

Garneau, Stewart C MD (UIA Investigator) has 63 clinical trials on record, with 15 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Garneau, Stewart C MD (UIA Investigator) accredited by Crixeo Clinical Trials?

Garneau, Stewart C MD (UIA Investigator) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Garneau, Stewart C MD (UIA Investigator)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.